The Monument Test : A New Tool for Assessing the Ability... | NCT07367880

Studies
The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO)

NCT07367880

Sponsor

University Hospital, Grenoble

Status

Recruiting

Last Update Posted

May 26, 2026Actual

Enrollment

220Estimated

Phase

Not provided

Conditions

Alzheimer s Disease

Interventions

Identification and naming task

Countries

France

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

ID	Type	Description	Link
2025-A01292-47	Other Identifier	ID RCB

Status Module

Record Verification Date

May 2026

Overall Recruitment Status or Expanded Access Status

Recruiting

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Feb 23, 2026Actual

Primary Completion Date

Feb 1, 2031Estimated

Completion Date

Feb 1, 2032Estimated

First Submitted Date

Dec 15, 2025

First Submission Date that Met QC Criteria

Jan 19, 2026

First Posted Date

Jan 26, 2026Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

May 22, 2026

Last Update Posted Date

May 26, 2026Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Yes

Target Follow-Up Duration

1 Month

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

220Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
People with Alzheimer Disease			Other: Identification and naming task
Healthy elderly people			Other: Identification and naming task

Interventions

Name	Type	Description	Arm Group Labels	Other Names
Identification and naming task	Other	Task of identification and naming of landmarks and celebrities	Healthy elderly people People with Alzheimer Disease

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Difference between the two groups in the identification and naming task involving famous landmarks	show a significant difference in performance between the two groups in the identification and naming task involving famous landmarks	1 month

Secondary Outcomes

Measure	Description	Time Frame
Development and standardization of a new tool for screening for naming disorders and visual identification of unique entities.		5 years

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion criteria :

Alzheimer's disease:
- Age ≥ 50 years and older
- Possible or probable diagnosis of Alzheimer's disease according to the revised criteria of Mac Khann et al., 2011.
- Score 18≤ MMSE ≤26
Controls:
- Age ≥ 50 years and older
- MMSE score ≥ 26 For all subjects
- No objection from the participant

Exclusion criteria

Alzheimer's disease:
- Persons referred to in Articles L1121-5 to L1121-8 of the CSP
Controls:
- Memory complaints
- Persons referred to in Articles L1121-5 to L1121-8 of the CSP For all subjects
- Significant neurological or psychiatric history
- Taking psychotropic medication (neuroleptics)
- Poor command of the French language, comprehension difficulties
- Significant hearing or visual impairments (diplopia, nystagmus, scotoma, etc.)
- Insufficient exposure to the media and/or socio-cultural knowledge (questionnaire) ; Deficit in face recognition (Benton Face Recognition Test)

Accepts Healthy Volunteers

Yes

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

50 Years

Maximum Age

95 Years

Standard Ages

AdultOlder Adult

Study Population

Participants in the MA group will be selected from among patients attending memory consultations at the CMRR at the CHU Grenoble-Alpes (active file within the department) or from among patients referred to the CMRR by a doctor not practicing at the CMRR (general practitioners or specialists such as neurologists). Healthy elderly participants will be recruited from among those accompanying patients being monitored at the CMRR.

Sampling Method

Probability Sample